INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
07/05/2026
Voltar para busca
Dado oficial do USPTO
MINORYX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
65
Atualização mais recente
08/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
28/10/2015
Data de registro
24/07/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/01/2025
Última transação
08/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
707
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Mataró, ES
Examinador
ASKEW, MEGAN RUTH
Localização atual
Historical data usage
Titulares e representantes
Titulares
Minoryx Therapeutics, S.L.
Minoryx Therapeutics, S.L.
Representantes
Elizabeth Lee D'Amore Lucas & Mercanti LLP
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
pharmaceutical products for human use for the treatment of rare diseases; diagnostic preparations for medical use; all of the foregoing excluding pharmaceutical and diagnostic products for dentistry use; all of the foregoing excluding dietary and nutritional supplements
Classe 42
scientific and technological servicesscientific research in the field of rare diseases and research and design relating thereto; research and development services and drug discovery servicesall for new techniques for medical diagnosis and medicinesdesign and development of software relating thereto ; research and development services and drug discovery services in the field of human health care
Classe 44
Medical services
Publicações
Histórico de despachos e eventos da marca no USPTO.
65 publicações encontradas
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
20/03/2026
INPC
INVALIDATION PROCESSED
20/03/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/12/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/12/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
28/09/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/09/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
28/01/2025
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
28/01/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/01/2025
ES71
TEAS SECTION 71 RECEIVED
24/07/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
24/07/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/11/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/11/2018
FIMP
FINAL DISPOSITION PROCESSED
09/11/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/10/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
24/07/2018
TMBN
TTAB RELEASE CASE TO TRADEMARKS
14/06/2018
OP.T
OPPOSITION TERMINATED NO. 999999
14/06/2018
OP.D
OPPOSITION DISMISSED NO. 999999
14/06/2018
EXPT
EXPARTE APPEAL TERMINATED
20/11/2017
RFNT
REFUSAL PROCESSED BY IB
17/11/2017
GPNX
NOTIFICATION PROCESSED BY IB
17/11/2017
OP.I
OPPOSITION INSTITUTED NO. 999999
30/10/2017
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
25/10/2017
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
25/10/2017
OPPF
OPPOSITION PAPERS RECEIVED AT TTAB
24/10/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/10/2017
PUBO
PUBLISHED FOR OPPOSITION
24/10/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/10/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/10/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/10/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/09/2017
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
06/09/2017
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
16/06/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/05/2017
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
31/05/2017
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
11/03/2017
GNSF
SUBSEQUENT FINAL EMAILED
11/03/2017
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
11/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/03/2017
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
03/03/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/03/2017
EXPI
EX PARTE APPEAL-INSTITUTED
01/03/2017
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
01/03/2017
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
01/03/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/09/2016
GNFR
FINAL REFUSAL E-MAILED
01/09/2016
CNFR
FINAL REFUSAL WRITTEN
01/09/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/08/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/08/2016
ALIE
ASSIGNED TO LIE
06/08/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/08/2016
RFNT
REFUSAL PROCESSED BY IB
11/03/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/02/2016
RFRR
REFUSAL PROCESSED BY MPU
22/02/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/02/2016
CNRT
NON-FINAL ACTION WRITTEN
20/02/2016
DOCK
ASSIGNED TO EXAMINER
20/02/2016
MAFR
APPLICATION FILING RECEIPT MAILED
09/01/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/01/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/01/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MINORYX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.